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A b s t r a c t  
Recently, lot of emphasis is being laid on oral controlled release multiple unit particulate (MUP) 
dosage forms, for their significant and potential benefits.  Ketorolac tromethamine (KTM) is a potent 
non-narcotic analgesic and anti-inflamatory drug administered orally in multiple divided doses (10 
mg four times a day) for the management of mild to moderate post-operative pain. KTMÊs short 
biological half-life demands frequent administration of the drug leading to poor patient compliance 
and inadequate pain management. Hence, the present investigation was undertaken to develop and 
evaluate oral controlled release mucoadhesive microspheres by ionotropic gelation method using 
natural and biodegradable polymers such as sodium carboxy methyl cellulose (Na CMC) and 
sodium alginate (SA). The influence of various formulation factors on the drug entrapment  
efficiency,  in vitro drug release, micromeritic properties, and  mucoadhesion ability  was 
investigated. Scanning electron micrographs of alginate beads loaded with drug exhibited rough 
surface morphology and  sizes were found to be  in the range of 842 to 1265 øm. Among all the 
formulations, the drug loaded microspheres of formulation CA6   showed the highest drug release 
retarding effect over a period of  8  hours.  The drug-polymer compatibility studies and solid state 
properties were investigated by Fourier transform infrared spectroscopy (FTIR), and differential 
scanning calorimetry (DSC) X- Ray diffraction techniques (X-RD). 
Keywords: Microspheres, Ketorolac tromethamine, controlled release, Ionotropic gelation technique, 
FTIR. 
 
Introduction 
Single-unit CR delivery systems or monolithic systems, generally 
may suffer from certain disadvantages such as  unintentional 
disintegration of the formulation due to technological  deficiency or 
abnormal  or unusual gastric physiology leading  to drastic changes 
in some patients.[1] Multi-particulate drug delivery systems contain 
a multiplicity of small individual  units, each capable of exhibiting 
required  characteristics. These systems, consists  of thousands of 
spherical particles with diameter of 0.05-2.00mm.[2] MUPs offer all 
the advantages of a single unit formulations yet devoid of the 
dangers of alteration in a drug release profile and formulation 
behavior due to unit to unit variation, change in gastro-luminal pH 
and enzyme population. Such benefits can lead to increased 
bioavailability, less risk of systemic toxicity, reduced risk of local 
irritation, and predictable gastric emptying. MUPs.[3] These drug 
delivery systems, because of the smaller particle size, are able to 
pass through the gastrointestinal (GI) tract easily, leading to less 
inter- and intra-subject variability and  dispersed  more uniformly 
along the GI tract and result in  more uniform drug absorption. The 
significant increase in the surface area of the drug loaded 
microspheres will enhance the  exposure of the drug  to the  
absorption site thus increasing the over all absorption of drug.[4]  
Moreover, MUPs can exhibit better in vivo performance than a 
single-unit system, as they show less erratic gastrointestinal transit 
times and are more sparsely scattered over the intestinal tract, thus 
providing greater uniformity of drug absorption, reduced potential 
for mucosal irritation and provide more reproducible drug 
release.[5] With these systems, even the safety profile the drug 
could be improved, mainly because the release characteristics are 
built into each sub unit.[6] These subunits units can either be filled 
into a sachet and encapsulated or compressed into a tablet.  
Numerous hydrophilic polymers, and in particular, polysaccharides, 
as well as their derivatives, have been employed in  the formulation 
of modified-release dosage forms.[7] Recently, alginate beads 
containing several substances have been prepared by the gelation 
of alginate with calcium cations and the behaviour of the release of 
these substances has been investigated.[8]  
Alginic acid is a linear block polysaccharide copolymer made of β-
D-mannuronic acid (M) and đ-L-guluronic acid (G) residues joined 
by 1,4 glycosidic linkages,and derived from sea weed. 
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The aqueous alginate solutions could form firm gels in presence of 
di- and tri-valent metal ions by a cooperative process involving 
consecutive guluronic residues in the G blocks of the alginate 
chain. The gelation or crosslinking is due to the stacking of the 
glucuronic acid blocks of alginate chains.[9]  
Sodium carboxy methyl cellulose (SCMC) is a water swellable 
semisynthtic polymer  belonging to the group of cellulose that could 
be used as a drug carrier.[10] It is used to make co-acervation with 
gelatin for the production of microcapsules.[11]  
The SR formulations of non-steroidal anti-inflammatory drug 
(NSAID) have been proved to minimize the side effects.[12] 
Ketorolac Tromethamine (KTM) is a well known non-steroidal anti-
inflammatory drug with potent analgesic activity prescribed for 
short term management of mild to moderate post-operative pain 
The half life of KTM ranges from 4-6 h.[13] When administered as 
the conventional formulations such as tablets or capsules, it 
causes gastro intestinal complications including irritation, ulcer, 
bleeding and perforation.[14] KTM is a relatively more favorable 
therapeutic agent for the management of moderate to severe 
pain.[15] The present study , therefore, undertaken to formulate 
and evaluate  controlled release mucoadhesive microspheres of 
drug using sodium alginate, SCMC. 
Materials and Methods   
Materials 
Sodium alginate and sodium carboxy methylcellulose were 
obtained from SD fine chemicals, Mumbai, India, KTM was 
obtained as a gift sample from Dr Reddy labs, Hyderabad, India. 
All the other chemicals used, were of analytical grade. 
Preparation of NaCMC-NaAlg spheres 
The ionic gelation method was employed for the preparation of 
microspheres followed by cross-linking with calcium chloride and 
aluminium chloride as cross linking agents. Solutions of sodium 
carboxymethyl cellulose (SCMC) and sodium alginate (total 
polymer concentration 4 % w/v) were prepared homogeneously 
using a magnetic stirrer.[16] Accurately weighed quantity of KTM 
was dissolved in the above solution and  20 ml of the solution was 
extruded into aqueous solution containing aluminium chloride 
(AlCl3) and calcium chloride (CaCl2) using 25 ml hypodermic 
syringe through a needle (number 23) under constant stirring. After 
incubating for additional 15 minutes in counter ion solution, they 
were removed, washed and dried at 40oC for 10 hrs and stored for 
further use. Different formulations were prepared and shown in 
table 1 
Percentage practical yield  
It is the quantity of quantity of beads obtained as a function of 
loaded drug and the polymer used. The yield of microspheres was 
determined by comparing the whole weight of microspheres formed 
against the combined weight of the copolymer and drug. 
 
 Mass of microspheres obtained 
 
% Practical yield =   ----------------------------------   X 100 
Total Wt of drug and polymer used 
Evaluation of the Microspheres 
Morphological and Micromeritic properties: 
Shape and size analysis of the prepared microspheres were 
performed by scanning electron microscopy (SEM) and optical 
microscopy. Optical micrometer was calibrated using stage 
micrometer and slides of dilute suspension of microspheres were 
prepared in liquid paraffin and were examined.[17] For SEM, 
samples of microspheres were mounted on metal stubs, gold 
coated under vacuum and examined in JEOL JSM-840 SEM 
Japan. 
Swelling behavior  
This property was studied by measuring the percentage water 
uptake by the microspheres. A known weight (50 mg) of  
microspheres was placed in a glass vial containing 100 ml of 
phosphate buffer (pH 7.4) and 0.1 N HCl (pH 1.2). They were 
removed from their respective swelling media periodically, blotted 
with filter paper and their change in weights were measured.  
Finally, the weight of the swollen microspheres was recorded after 
a period of 6 hours, and the swelling ratio (SR) was then 
calculated.18]  
Determination of Encapsulation Efficiency  
The drug entrapment efficiency of the beads was calculated from 
the ratio of actual to theoretical drug content. 100 mg of the 
microspheres  were accurately weighed and crushed and this 
powder was added to  500 ml of pH 7.4 buffer and kept aside for 
about 24 hours with occasional shaking. The debris of the beads 
formed after disintegration was taken out and removed by filtering 
through Whatman filter paper (No. 40). The absorbance of the 
filtrate was measured using a UV Vis spectrophotometer (Lab India 
) at 322 nm.[19] 
In vitro drug release studies  
The in vitro dissolution study was carried out using dissolution rate 
test apparatus USP at 50 rpm. The dissolution medium consisted 
of 900ml simulated gastric fluid (pH 1.2) for first 2hrs followed by 
simulated intestinal fluid (pH 7.2) from 2 to 8 hrs. The samples 
were withdrawn at predetermined  intervals and analyzed for drug 
content.[20] by UV-Visible Spectrophotometer at 322 nm. Three 
dissolution runs were conducted for each batch and the averaged 
results were taken. 
Mucoadhesion testing  
Test for mucoadhesion was carried out as per in vitro wash-off 
method.[21] Freshly excised pieces of goat intestinal mucosa (1 
cm_1 cm, procured from a slaughter house) was mounted on a 
glass slide (7.5 cm_2.5 cm) using thread. Approximately, 100 
beads were evenly spread out on each piece of mucosa and then 
hung from the arm of the tablet disintegration test apparatus. The 
tissue specimen was given a regular up and down movement in a 
vessel containing 900 ml of 0.1 N HCl (pH 1.2) and phosphate 
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buffer (pH 7.4) maintained at 37_0.5 ĈC. The adherence of beads 
was regularly observed. The beads that remained adhered to the 
mucosa were counted at regular intervals for up to 10 h. 
Fourier Transform infrared Spectroscope 
FTIR spectra of the drug, polymer and drug loaded beads were 
taken by KBr pellet method and compared to assess drug excipient 
compatibility.[21] 
Differential scanning calorimetry (DSC)  
DSC determines the physical state of the drug. Any changes in the 
solid state would alter the drug release profile from the 
microspheres. DSC thermograms were obtained  by taking about 2 
mg sample was placing in pierced aluminium pans and heated at a 
scanning rate of 10ÀC per minute from 50 to 250 ÀC. The 
instrument was calibrated with an indium standard.[22] 
X-ray diffraction technique (XRD) 
The determination of physical state of the drug in the drug delivery 
system is essential due to the probability of change in solid state of 
the drug during the process, and such changes may in turn impact 
the drug release properties. The solid state properties of the drug 
are studied  by X-ray powder diffraction technique (XRD).[23] 
Results and Discussion 
Size, Shape and percentage yield 
The keterolac tromethamine loaded microspheres  of NaCMC and  
SA and were prepared by ionotropic gelation method using 
aluminum chloride and calcium chloride as cross linking agents.  
The polymer sod. alginate was used  to control the release rate 
and NaCMC as a mucoadhesive polymer. 
The obtained micro-beads were spherical in shape and freely 
flowing. The surface morphology was examined by scanning 
electron microscopy studies (SEM) and presented in Figure 1A and 
B respectively.  The prepared beads are spherical, having rough 
and dense surface along with surface foldings and visible 
microscopic cracks. A similar kind of morphology was noted 
previously for beads made of alginates when the solid drug was 
microencapsulated.[24] The mean particle sizes of the obtained 
alginate beads are shown Table 2. Spherical microspheres were 
smaller in size at equal ratios of the polymers SA:SCMC and 
larger, when one of the polymer ratio is reduced. This could mean 
that the ratio of the two polymers has critical values for controlling 
the particle size of the micro spheres.[25]  Finally, the mean 
particle size was increased from 954 um to1265 um when the 
sodium alginate polymer concentration was increased from 1% to 
3% (w/w).Generally, the particle sizes were in the acceptable size 
range of microcapsules. It was observed that surface morphology 
and size of microspheres were  dependent  on the amount  of both 
the polymers. Also, the microspheres which contained higher 
proportion of sod. alginate has some rough surface as the 
proportion of sod. alginate decreases. The presence Na CMC, 
appears to impart  smoothness to the  surface.  
The percentage practical yield of all the formulations (CA1 ăCA6) 
was found to be within the range of 80.12 to 91.12 % which 
indicates the suitability of the method in preparing the micro 
spheres. The percentage practical yield is depicted in Table.2. 
Drug entrapment efficacy 
The drug entrapment efficacy of all the formulation was in the 
range of 61.76 ă 72.50. The drug entrapment efficacy of 
microspheres was noted to increases with increase in 
concentration of hydrophilic polymers. Amongst formulations (CA1-
CA6) CA5 and CA6 have shown good entrapment efficiency. Over 
all, it is observed that there was not much difference in their 
capacity to entrap drug (Table 2). The highest drug entrapment 
efficiency was noted in alginate-Na CMC beads at 4.5 % w/v 
Calcium chloride and Aluminium chloride.  The lowest drug 
entrapment efficiency of KTM was observed at low cross-linking 
agent concentration (2.5 % w/v CaCl2 and aluminium chloride). At 
lower concentrations of cross linking agents, the beads showed 
larger pores due to insufficient cross-linking which results in lower 
drug entrapment. 
 
Swelling behavior 
Swelling behavior is one of the critical factors which influence the 
drug release profile from the drug loaded beads. Therefore, the 
swelling behavior of KTM-loaded alginate-CMC beads were 
evaluated and shown in table 3 and depicted in fig 3 Maximum 
swelling of beads was noticed at 3ă5 hrs in phosphate buffer after 
which erosion and breakdown started to take place. This type of 
behavior may result from gradual erosion of crosslinking of alginate 
backbone into smaller fragments. Also, the exchange of Ca2+ ions 
present in the microspheres with Na+ ions of the phosphate buffer 
would cause a prolonged erosion of the microspheres which in turn 
significantly increases the drug release rate in the phosphate 
buffer. These results clearly indicate that the beads will swell to a 
lesser extent in the stomach before they move to the upper 
intestine where the drug is absorbed and the alginate-CMC beads 
starts to swell to their maximum extent and behave as hydrophilic 
matrices for the controlled release of the drug in the intestine. 
In vitro dissolution studies  
The data from in vitro drug release profile of all the formulations 
was depicted in the figure 4. From the study, it is revealed that CA5 
and CA6 formulations exhibited better drug release retarding ability 
at the end of 8 hrs releasing of the drug 78.50% and 73.05% 
respectively, In comparison with other formulations. On the other 
hand, it is found that the formulation CA1 could release almost all 
of its drug content at the end of 8 hrs. The release profile of KTM 
from micro spheres exhibited more sustained nature of release 
when the sodium alginate and NaCMC were incorporated at 2 % 
each. 
DSC Analysis 
The DSC analysis of plain KTM, drug-free beads and a drug-
loaded micro spheres was carried out and the results are shown in 
Figure 2. The drug-free beads have shown an endothermic peak at 
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100.76 oC due to associated free and bound water, another peak is 
seen at 195.9 oC, may be due to melting temperature of the 
polymer. Whereas drug-loaded beads have shown an endothermic 
peak at 91.31 oC, due to free and bound water present in the 
matrix. The plain keterolac has shown a sharp endothermic peak at 
168.9 oC due to melting of the drug. However, this peak is 
observed in the drug-loaded beads at 167 oC, indicating the 
stability of drug in the polymer matrix. 
X-ray diffraction studies 
The x-ray diffraction studies are useful to investigate the 
crystallinity of the drugs after entrapment into the dosage forms. 
The X-ray diffractograms of plain KTM, drug free beads and drug-
loaded beads are presented in Fig. 3. Keterolac has shown 
characteristic intense peaks between the 2θ of 10o and 40o due to 
its crystalline nature. Whereas, in case of drug loaded beads, no 
intense peaks related to drug were noticed between the 2θ of 10o 
and 40o. However, a peak at 10o observed in both drug free and 
drug loaded beads may be attributed to the polymer 
crystallinity/noise. This indicates the amorphous dispersion of the 
drug after entrapment into beads. 
Results of FTIR 
The IR spectrum of pure KTM  shows  a peak at  3446.79 cm-1 
which is attributed to  the N-H and NH2 stretching and peaks at 
1469.76 cm-1, 1490.97 cm-1 are due to C=C aromatic and 
aliphatic stretching, peak at 1381.03cm-1 is due to ăC-N vibrations, 
peak at 1049.28 cm-1 is due to ăOH bending confirms presence of 
alcoholic group, peaks at 702.09, 725.23, 763.81 and 798.53 cm-1 
confirms the C-H bending (aromatic). Hence, it is   thus, conforms 
the structure of drug KTM (Figure 3). Figure: 7 
From the examination of the recorded IR spectral data, it can be 
seen that all the characteristic peaks of the drug are also seen in 
the IR spectra of the physical  mixture of drug and excipients and 
some more  peaks were observed with physical mixtures, which 
could be attributed to the presence of polymers( Figure: 11) These 
results indicate that there is no interaction between the drug and 
polymers taken up for the investigation. 
 
Table 1: Properties of KTM loaded alginate microspheres formulations 
Formulation code Mean particle 
size(øm) 
% Encapsulation 
efficiancy 
Drug content mg/100 
of beads 
% Practical yield
CA1 1265μ0.53 61.76μ1.4 12.35 81.15
CA2 1052 μ 0.45 
 
63.37μ1.3 12.67 80.12
CA3 954μ 0.59 
 
65.52μ1.1 13.10 82.14
CA4 992μ0.28 
 
68.75μ0.9 13.75 85.10
CA5 901μ 0.32 
 
70.89μ1.5 14.17 89.15
CA6 842μ 0.44 
 
72.50μ2.2 29.00 91.13
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Table 2. Percentage drug release 
 
 
 
 
 
 
Figure 1. Scanning electron microscopic photographs of microbeads (A) and its surface morphology (B). 
 
Sl.No Code 1 Hr 2 Hr 3 Hr 4 Hr 5 Hr 6 Hr 7 Hr 8 Hr
1 CA1 37.391 62.915 84.217 90.455 92.950 94.354 95.914 98.409
2 CA2 33.48742812 54.7364789 76.00907809 83.76200406 86.80236718 89.538694 91.21089371 94.25125684
3 CA3 27.79322866 49.09271231 67.0894823 76.04453355 79.5678324 82.50391478 85.58680127 88.81649189
4 CA4 30.73321859 49.5697074 69.05836576 77.60311284 82.50583658 86.14785992 87.82879377 90.35019455
5 CA5 22.47110546 40.13555734 56.50529874 64.79093149 68.86583284 71.98992388 75.52150505 78.50976604
6 CA6 20.85880468 37.01703365 53.79712867 62.0991547 67.08037032 69.73701865 72.06158594 73.05782906
(A) 
(B) 
Rao et al. International Journal of Drug Delivery 6 (2) 121-132 [2014] 
 
PAGE | 126 |
 
 
Figure 2 Drug release behavior of beads in pH 1.2 and pH 7.4 solutions 
 
Figure 3 Swelling behaviour of beads in phosphate buffer pH 7.4 
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Figure 4. , FT-IR Spectra of KTM. 
 
Figure 5. FT-IR spectra of Sodium alginate. 
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ăăă ăăă 
Figure 6 FT-IR spectra of Sodium CMC. 
 
Figure7. FT-IR spectra of drug and polymers 
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Figure. 2. DSC thermograms of keterolac tromethamine (A), drug free CA6 beads (B) and drug loaded CA6 beads (C). 
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        Figure 3. X-ray diffractograms of keterolac tromethamine (A), drug free CA6 beads (B) and drug loaded CA 6beads (C). 
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Conclusion 
The ionotropic gelation method was successfully applied in 
preparing  KTM loaded beads which demonstrated a satisfactory 
sustained-release characteristics, suggesting that Sod .alginate 
and Na CMC were  effective natural polymer in for MUPs. The drug 
loaded formulations prepared from sodium alginate and sodium 
CMC at the concentrations of 2% weight ratios each with 3.5% 
weight ratios of  calcium chloride and aluminium chloride  as cross 
linking agents showed the lowest drug release of 73.07 % at the 
end of 8 hrs. FTIR Spectroscopy demonstrated  that there is no 
chemical interaction between the drug and polymers. DSC and X-
Rd data indicated the no change in the physical state of the drug in 
the formulations.   
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